Overview of COVID-19 : Current scenario and role of Ayurvedic measures
Abstract
Viral diseases are one of the major causes of devastation in human history world wide. Bacterial and parasitic diseases can be controlled by the use of effective antibodies and anti-parasitic agents respectively. Since viruses do replicate inside the cells and any intervention will affect the cellular metabolism of the host. Development of antiviral drug is a challenge. COVID-19 is the infectious disease caused by the most recently discovered corona virus. This new virus and disease were unknown before the outbreak began in Wuhan, China, in December 2019. COVID -19 is declared as a pandemic by WHO in the month of March. No cure has yet been found for the disease; however, nowadays it is being managed through symptomatic treatment by using corticosteroids and antibiotics to prevent or subside bacterial infections. As all infected people do not develop severe disease and even most of them are having either mild symptoms or symptoms less. From the recent data we found that most of the patients who developed severe symptoms have already had some chronic ailments like diabetes, HTN and were already in an immune-compromised state. So, through Ayurvedic approach we can try to boost up immunity of the patient and hence can reduce the mortality rate and burden of providing health facilities in our country.
Downloads
References
https://www.who.int/health-topics/coronavirus#tab=tab_1. https://www.mayocl
inic.org/diseases-conditions/coronavirus/symptomscauses/syc-20479963
https://www.ncbi.nlm.nih.gov/books/NBK554776/
Q&A on coronaviruses (COVID-19)". World Health Organization. 17 April 2020. Archived from the original on 14 May 2020. Retrieved 14 May2020
Nussbaumer-Streit B, Mayr V, Dobrescu AI, Chapman A, Persad E, Klerings I, et al. (April 2020). "Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review". The Cochrane Database of Systematic Reviews. 4: CD013574. doi:10.1002/14651858.CD013574. PMC 7141753. PMID 32267544.
COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)". ArcGIS. Johns Hopkins University. Retrieved 12 August 2020.
Coronavirus disease 2019 (COVID-19)—Symptoms and causes". Mayo Clinic. Retrieved 14 April 2020.
Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, et al. (February 2020). "The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China". International Journal of Infectious Diseases. 91: 264– 266. doi:10.1016/j.ijid.2020.01.009. PMC 7128332. PMID 319 53166.
WHO Director-General's opening remarks at the media briefing on COVID-19". World Health Organization (WHO) (Press release). 11 March 2020. Archived from the original on 11 March 2020. Retrieved 12 March 2020.
WHO Coronavirus Disease (COVID-19) Dashboard | WHO ...covid19.who.int
Channappanavar R., Zhao J., Perlman S. T cell-mediated immune response to respiratory coronaviruses. Journal. 2014;59:118–128. [PMC free article] [PubMed] [Google Scholar]
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.